J. P. Benya
Operationeel Directeur bij Flame Biosciences LLC
Oorsprong van het eerstegraads netwerk van J. P. Benya
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 27 | |
Flame Biosciences LLC
 Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY.
7
| Subsidiary | Miscellaneous Commercial Services | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met J. P. Benya via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| E I DU PONT DE NEMOURS AND CO | Chemicals: Agricultural | Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Pharmaceuticals: Major | Director/Board Member | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| AETHLON MEDICAL, INC. | Medical Specialties | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| XOMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Founder | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
| INTERMUNE INC | Biotechnology | Chief Executive Officer | |
Marcadia Biotech, Inc.
 Marcadia Biotech, Inc. Pharmaceuticals: MajorHealth Technology Marcadia Biotech, Inc. develops therapeutic products for diabetes and obesity. It is a biopharmaceutical company focuses on developing a broad portfolio of drug candidates for treatment of diabetes and obesity. The company was founded in 2005 and is headquartered in Carmel, IN. | Pharmaceuticals: Major | Founder Director/Board Member | |
Naurex, Inc.
 Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Michigan State University | College/University | Doctorate Degree Graduate Degree | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
| University of Dayton | College/University | Masters Business Admin | |
| University of Kansas | College/University | Doctorate Degree | |
BioCrossroads
 BioCrossroads Investment ManagersFinance BioCrossroads (BioCrossroads) is a venture capital firm founded in 2002. The firm is headquartered in Indianapolis, Indiana. | Investment Managers | Director/Board Member Director/Board Member Director/Board Member | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Chicago Booth School of Business | College/University | Graduate Degree Masters Business Admin | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| APPLIED MOLECULAR TRANSPORT INC. | Biotechnology | Chairman Director/Board Member | |
| PARDES BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder General Counsel | |
| Defense Sciences Research Council | Corporate Officer/Principal Corporate Officer/Principal | ||
Indel Therapeutics, Inc.
 Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Biotechnology | Founder Director/Board Member | |
| DERMIRA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Luson Bioventures LLC
 Luson Bioventures LLC Investment ManagersFinance Luson Bioventures LLC operates as an biotechnology and biopharmaceutical venture creation firm. The company was founded by Derek A. Small in 2007 and is headquartered in Zionsville, IN. | Investment Managers | Founder | |
| Kinagen, Inc. | Corporate Officer/Principal | ||
| Franklin College of Indiana, Inc. | College/University | Undergraduate Degree | |
Gate Neurosciences, Inc.
 Gate Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Gate Neurosciences, Inc. engages in the provision of pharmaceutical services. The company is headquartered in Carmel, IN. | Pharmaceuticals: Major | Founder | |
Anagin, Inc.
 Anagin, Inc. Pharmaceuticals: MajorHealth Technology Anagin, Inc. develops targeted therapies for pathologies associated with disrupted synaptic plasticity in the central nervous system leading to psychiatric diseases. It targeted diseases such as post traumatic stress disorder (PTSD), traumatic brain injury (TBI), depression, neuropathic pain, Alzheimer’s disease and Parkinson’s disease. The company was founded by Anatha Shekhar and Yvonne Lai in 2013 and is headquartered in Indianapolis, IN. | Pharmaceuticals: Major | Director/Board Member | |
| Harlaxton College | College/University | Undergraduate Degree | |
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| Merck Sharp & Dohme Research Laboratories | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 47 |
| Canada | 2 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 33 |
| Consumer Services | 8 |
| Finance | 4 |
| Process Industries | 2 |
| Retail Trade | 2 |
Operationeel
| Director/Board Member | 129 |
| Corporate Officer/Principal | 92 |
| Chief Executive Officer | 33 |
| Chief Tech/Sci/R&D Officer | 31 |
| Independent Dir/Board Member | 29 |
Sterkste connecties
| Insiders | |
|---|---|
| Helen Kim | 34 |
| Alan J. Lewis | 33 |
| William Ringo | 32 |
| Susan Mahony | 21 |
| Russell Ellison | 20 |
| Derek Small | 16 |
| Richard DiMarchi | 16 |
| Charles Fisher | 16 |
| John McHutchison | 14 |
| Graham Cooper | 14 |
| Lee Arnold | 13 |
| David R. Houck | 11 |
| Michael Samar | 10 |
| Patrick Scannon | 10 |
| David Barrett | 9 |
- Beurs
- Insiders
- J. P. Benya
- Bedrijfsconnecties
